Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. The Company develops a biologic drug candidate based on academic research on a platelet glycoprotein called GPVI.
|Employees (est.) (Oct 2019)||15||(+8%)|
Acticor Biotech total Funding
Acticor Biotech latest funding size
Time since last funding
|a year ago|
Acticor Biotech investors
|CapDecisif Management, Anaxago, ARMESA, Primer Capital, CapDicisif Management, Mirae Asset Financial Group, Newton Biocapital, CMS Midical Venture Investment, A&B (HK)|
Acticor Biotech has 306 Twitter Followers. The number of followers has increased 1.2% month over month and increased 1.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Acticor Biotech founded?
Acticor Biotech was founded in 2013.
Who are Acticor Biotech key executives?
Acticor Biotech's key executives are Gilles Avenard, Eric Cohen and Yannick Plétan.
How many employees does Acticor Biotech have?
Acticor Biotech has 15 employees.
Who are Acticor Biotech competitors?
Competitors of Acticor Biotech include Seelos Therapeutics, Omeros and Albireo Pharma.
Where is Acticor Biotech headquarters?
Acticor Biotech headquarters is located at 46 Rue Henri Huchard, Paris.
Where are Acticor Biotech offices?
Acticor Biotech has an office in Paris.
How many offices does Acticor Biotech have?
Acticor Biotech has 1 office.
Receive alerts for 300+ data fields across thousands of companies